SFL will host a free webinar on ‘Regulatory considerations for orphan drugs’ on 24 February 2022, 4-5 pm CET.

SFL regulatory affairs experts will provide an introduction to the framework for orphan drugs in the European Union, the United Kingdom and Switzerland, and share their insights on opportunities and challenges for orphan drug designation and marketing authorization applications across these key regions. They will also provide insights into the revision of the EU orphan legislation.

The webinar will be presented by Anja Bührer, Head Global Regulatory Affairs, Julien Gaudias, Head EU Regulatory Affairs and Ben Stockham, Senior Consultant Global Regulatory Affairs at SFL.

You can register now via this link.